The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...

The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another condition is causing a person’s cognitive symptoms.

How does donanemab work? There are more than 100 different causes of dementia, but Alzheimer’s disease alone accounts for about 70% of these, making it the most common form of dementia.. The ...

According to the nonprofit Alzheimer's Impact Movement, federal funding for Alzheimer's research accounts for as much as $3.8 billion each year. "Reduced research funding means we are delaying the ...

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease; The test measures two proteins, beta-amyloid and p-tau217, which are hallmarks of the disease ...

Alzheimer’s disease primarily affects people over the age of 65, but it’s never too early to be aware of the warning signs of this common brain disorder. And you may be able to detect them ...

A survey of 1,700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's disease. Accessibility links. Skip to main content; ...

A blood test that can help diagnose Alzheimer’s disease has received clearance from the Food and Drug Administration. This is a step toward a goal of scientists and doctors to one day be able to ...